Krishna Institute of Medical Sciences Ltd

Q3 FY26Healthcare Services

Krishna Institute of Medical Sciences Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹782

Market cap₹33.7K Cr

P/E161.5

Updated23 Aug 2026

Read5 min read

The short version

Management expects to double the top line within 3 years, and currently is performing better than that target (Page 19). Management expects no incremental debt going forward; debt to reduce quarter-on-quarter (Pg.19).

From Krishna Institute of Medical Sciences Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Management expects to double the top line within 3 years, and currently is performing better than that target (Page 19).
Growth is anticipated from expanding specialties at existing hospitals without additional capex, contributing incremental revenue (Page 19).
New hospitals like Thane and Bangalore clusters (Mahadevapura, Electronic City) are ramping up, with break-even expected by early to mid FY '27, supporting revenue growth (Pages 12-13).
Telangana market is mature; expected occupancy growth to around 75-80% over 3-4 years with addition of beds boosting volume growth (Page 11).
Tier 2 markets like Nashik had slower ramp-up due to payer mix but are now EBITDA positive with improved corporate empanelments expected to drive growth (Page 14).

2 more points management made on revenue & sales performance

Profitability & Margins

Management expects no incremental debt going forward; debt to reduce quarter-on-quarter (Pg.19).
Expansion primarily involves adding specialties in existing facilities with minimal capex, enabling incremental revenue (Pg.19).
Target to double top-line within 3 years, currently outperforming previous guidance (Pg.19).
Hospitals like Kondapur to see 20-25% year-on-year growth post new facility commissioning (Pg.18).
Break-even expected in new units: Thane and Mahadevapura by Q1 FY '27; Electronic City by Q3 FY '27 (Pg.13).
Capex for FY '27 expected to be INR 500-600 crores; minimal further capex planned for FY '28 (Pg.18).
EBITDA and profitability to improve as new hospitals stabilize and occupancy increases (Pg.13).

2 more points management made on profitability & margins

See what Krishna Institute of Medical Sciences Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

For FY '27, an incremental capex of INR 500-600 crores is planned, primarily related to completing the full closure and setup of new facilities (Page 17).
No concrete capex plans for FY '28 yet, as no new hospitals are currently scheduled for commissioning (Page 17).
Post current major expansions, further expansions or new hospital additions may require exploring non-debt funding sources (Page 19).
Expansion focus includes operationalizing and scaling existing new hospitals, especially large facilities like Kondapur (Page 16-17).
Additional capacity additions in Bangalore planned on existing land already owned (Page 16).

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Current debt stands at around INR 2,800 crores, expected to come down quarter-on-quarter as INR 600 crores is receivable from government creditors.
The company currently holds INR 200 crores cash, and no incremental debt is anticipated moving forward unless new large expansions are announced.
For new expansions or opportunities, other means of funding besides debt will be explored.
Capex for FY '27 is estimated around INR 500-600 crores mainly for the full closure of the old hospital and related investments; no major capex planned for FY '28 yet.

2 more points management made on fundraising & capital structure

See what Krishna Institute of Medical Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Based on the transcript of the KIMS Hospitals Q3 FY 2026 earnings call: - No explicit mention of a current or expected order book or pending orders was made during the call. - Expansion plans currently remain limited to previously announced hospitals with no new hospitals added beyond those already disclosed. - There are mentions of ongoing expansion through adding new specialties at existing facilities without additional capex. - Small acquisition opportunities have been considered but none considered sizable or significant at this time.

2 more points management made on order book & pipeline

Krishna Institute of Medical Sciences Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Krishna Institu.'s management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Krishna Institute of Medical Sciences Ltd Q3 FY26 results?

What is Krishna Institute of Medical Sciences Ltd share price analysis?

Krishna Institute of Medical Sciences Ltd currently shows a neutral. The stock trades at a P/E of 161.5 with a market cap of ₹33,691 Cr. Investors should review the full earnings analysis for detailed insights.

Is Krishna Institute of Medical Sciences Ltd planning capital expenditure?

For FY '27, an incremental capex of INR 500-600 crores is planned, primarily related to completing the full closure and setup of new facilities (Page 17).

Keep Krishna Institute of Medical Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.